» Articles » PMID: 15761666

Emerging Roles of Thioredoxin Cycle Enzymes in the Central Nervous System

Overview
Publisher Springer
Specialty Biology
Date 2005 Mar 12
PMID 15761666
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

The thioredoxins (Trxs) constitute a family of enzymes which catalyze the reduction of protein disulfide bonds. Recent animal studies have revealed the importance of the Trx superfamily in various experimental systems. For example, the homozygous disruption of the genes encoding cytoplasmic (TRX1) or mitochondrial Trx (TRX2) in mice generates lethal embryonic phenotypes. In contrast, transgenic mice overexpressing TRX1 show an extended life span and are relatively resistant to ischemia- mediated brain damage. In addition to their capacity to detoxify peroxides in concert with peroxiredoxins and Trx reductases, Trx isozymes perform multiple redox signaling functions mediated by their specific interaction with various proteins, including redox-regulated kinases and transcription factors. Recent studies indicate that specific isoforms of Trx cycle enzymes, targeted to different cell compartments, are key regulators of fundamental processes, such as gene expression, cell growth and apoptosis. The present review is primarily focused on the emerging neuroprotective role of these proteins in the central nervous system.

Citing Articles

Redox Regulation of K Channel: Role of Thioredoxin.

Hilgers R, Das K Antioxid Redox Signal. 2024; 41(13-15):818-844.

PMID: 39099341 PMC: 11631806. DOI: 10.1089/ars.2023.0416.


Molecular characterization and functional analysis of peroxiredoxin 1 (Prx1) from roughskin sculpin (Trachidermus fasciatus).

Liu Y, Cong H, Bi C, Zha H, Yu S, Zhao L Fish Physiol Biochem. 2023; 50(2):513-526.

PMID: 38103084 DOI: 10.1007/s10695-023-01281-7.


Efficacy and safety of probiotics in Parkinson's constipation: A systematic review and meta-analysis.

Xie L, Chen D, Zhu X, Cheng C Front Pharmacol. 2023; 13:1007654.

PMID: 36703760 PMC: 9871263. DOI: 10.3389/fphar.2022.1007654.


CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits A -Induced SH-SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway.

Guo C, Li Q, Xiao J, Zhou X, Tian M, Xie L Comput Math Methods Med. 2022; 2022:1949344.

PMID: 36118839 PMC: 9477634. DOI: 10.1155/2022/1949344.


Compensatory Neuroprotective Response of Thioredoxin Reductase against Oxidative-Nitrosative Stress Induced by Experimental Autoimmune Encephalomyelitis in Rats: Modulation by Theta Burst Stimulation.

Stevanovic I, Ninkovic M, Mancic B, Milivojevic M, Stojanovic I, Ilic T Molecules. 2020; 25(17).

PMID: 32867364 PMC: 7503723. DOI: 10.3390/molecules25173922.


References
1.
Dans A, Connolly S, Wallentin L, Yang S, Nakamya J, Brueckmann M . Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation. 2012; 127(5):634-40. DOI: 10.1161/CIRCULATIONAHA.112.115386. View

2.
Bonaca M, Bhatt D, Cohen M, Steg P, Storey R, Jensen E . Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015; 372(19):1791-800. DOI: 10.1056/NEJMoa1500857. View

3.
Mockel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K . Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J. 2014; 36(6):369-76. PMC: 4320319. DOI: 10.1093/eurheartj/ehu178. View

4.
Montalescot G, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay J . Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med. 2013; 369(11):999-1010. DOI: 10.1056/NEJMoa1308075. View

5.
Neumann J, Sorensen N, Schwemer T, Ojeda F, Bourry R, Sciacca V . Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm. JAMA Cardiol. 2016; 1(4):397-404. DOI: 10.1001/jamacardio.2016.0695. View